Cardiac transplantation: Current indications, short- and long-term results, economic implications, and future developments

Journal of Cardiac Failure

Volumn 2, Issue 2, 1996, Pages 141-152

  Olivari, Maria Teresa ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMICS; FORECASTING; HEART TRANSPLANTATION; HUMAN; MORTALITY; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

FORECASTING; HEART TRANSPLANTATION; HUMANS; PATIENT SELECTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0030162156     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(96)80033-9     Document Type: Review

References (10)

1. Hosenpud JD, Novick RJ, Breen TJ, Keck B, Daily P: The registry of the International Society for Heart and Lung Transplantation: twelfth official report - 1995. J Heart Lung Transplant 1995;14:805-15
2. O'Connell JB, Bourge RC, Costanzo-Nordin MR, Driscoll DJ, Morgan JP, Rose EA, Uretsky BF: Cardiac transplantation: recipient selection, donor procurement and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86:1061-79
3. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E: Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92: 3592-612
4. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME, Stevenson LW: 24th Bethesda Conference on cardiac transplantation. Task force 3: recipient guidelines/prioritization. J Am Coll Cardiol 1993;22:21-31
5. Cohn JN, Archibald DG, Francis GS, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B: Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of pre-randomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation 1987;75(suppl IV):IV-49-54
6. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;327:685-91
7. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-35
8. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group: beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342:1441-6
9. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM: Effect of carvedilol on the survival of patients with chronic heart failure. (abstract) Circulation 1995;92(suppl I):I-142
10. Milano CA, White WD, Smith R, Jones RH, Lowe JE, Smith PK, Van Trigt P III: Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg 1993;56:487-93